Peter Lang Selected Research

Neoplasms (Cancer)

1/2024	Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
1/2024	A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.
11/2023	Application of the National Comprehensive Cancer Network-distress thermometer in pediatric patients during autologous and allogeneic hematopoietic stem cell transplantation and relationship to blood parameters of the stress axis.
9/2023	Impact of a mental training program for pediatric cancer patients after allogeneic hematopoietic stem cell transplantation or high-dose chemotherapy - Results of a randomized controlled trial.
1/2023	Rare and potentially fatal - Cytogenetically cryptic TNIP1::PDGFRB and PCM1::FGFR1 fusion leading to myeloid/lymphoid neoplasms with eosinophilia in children.
1/2023	Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN.
10/2022	Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells.
1/2022	Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients.
1/2022	131I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors.
1/2022	Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Lang Research Topics

Disease

33	Neoplasms (Cancer) 01/2024 - 01/2004
24	Leukemia 11/2023 - 02/2003
21	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 02/2003
19	Infections 01/2023 - 12/2003
16	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2023 - 12/2003
15	Neuroblastoma 01/2024 - 05/2006
7	Residual Neoplasm 11/2022 - 09/2010
6	Lymphoma (Lymphomas) 05/2024 - 11/2004
6	Viremia 01/2023 - 11/2010
6	Adenoviridae Infections (Adenovirus Infections) 08/2021 - 02/2005
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2014 - 11/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 12/2003
5	COVID-19 01/2022 - 11/2020
4	Virus Diseases (Viral Diseases) 01/2023 - 07/2006
4	Disease Progression 10/2020 - 07/2009
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 04/2006
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2024 - 07/2009
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 02/2024 - 09/2020
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2024 - 01/2005
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2018
3	Vomiting 04/2020 - 01/2019
3	Mycoses (Diseases, Fungus) 08/2015 - 07/2012
3	Inflammation (Inflammations) 10/2014 - 03/2010
2	Inborn Genetic Diseases (Disease, Hereditary) 02/2024 - 10/2019
2	Thalassemia 02/2024 - 01/2018
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2023 - 01/2016
2	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2022
2	Medulloblastoma 01/2023 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2004
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 10/2020
2	Acute Promyelocytic Leukemia 08/2021 - 05/2011
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 10/2019
2	Hemorrhage 10/2020 - 07/2007
2	Nausea 04/2020 - 01/2019
2	Hemoglobinopathies 01/2019 - 01/2018
2	Osteonecrosis (Kienbock's Disease) 10/2018 - 08/2012
2	Cytopenia 01/2018 - 03/2005
2	Body Weight (Weight, Body) 01/2017 - 10/2012
2	Sepsis (Septicemia) 01/2016 - 08/2015
2	Bacteremia 01/2016 - 08/2015
2	Autoimmune Diseases (Autoimmune Disease) 08/2012 - 04/2004
2	Pulmonary Aspergillosis 08/2012 - 01/2012
2	Juvenile Myelomonocytic Leukemia 09/2011 - 02/2003
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2008 - 04/2004
2	Arteriovenous Malformations (Arteriovenous Malformation) 11/2005 - 11/2005
2	Heterotaxy Syndrome 11/2005 - 11/2005
2	Lymphopenia (Lymphocytopenia) 03/2005 - 03/2004
1	Retinoblastoma (Glioblastoma, Retinal) 01/2024
1	Osteosarcoma (Osteogenic Sarcoma) 01/2024

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2004
6	dinutuximabIBA 01/2024 - 01/2021
5	CytokinesIBA 11/2023 - 01/2004
5	SteroidsIBA 01/2021 - 03/2010
5	AntigensIBA 01/2021 - 04/2004
4	Proteins (Proteins, Gene)FDA Link 07/2012 - 05/2008
3	Monoclonal AntibodiesIBA 01/2024 - 01/2014
3	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2020
3	AntibodiesIBA 01/2024 - 01/2013
3	Interleukin-2 (IL2)IBA 10/2023 - 09/2011
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2014
3	Peptides (Polypeptides)IBA 01/2022 - 11/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
3	blinatumomabIBA 06/2021 - 07/2014
3	KIR ReceptorsIBA 01/2015 - 04/2004
3	LigandsIBA 01/2015 - 01/2004
2	EnzymesIBA 02/2024 - 01/2022
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 02/2024 - 01/2022
2	Busulfan (Busulfex)FDA Link 02/2024 - 10/2020
2	Complement System Proteins (Complement)IBA 01/2024 - 01/2021
2	Rituximab (Mabthera)FDA Link 01/2023 - 12/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 10/2022 - 01/2018
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2019
2	Arsenic Trioxide (Trisenox)FDA Link 08/2021 - 05/2011
2	fosaprepitant FDA Link 01/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 12/2019
2	AntiemeticsIBA 01/2020 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2013
2	posaconazole FDA Link 07/2017 - 10/2012
2	Immunoglobulins (Immunoglobulin)IBA 12/2014 - 07/2014
2	liposomal amphotericin B FDA Link 07/2012 - 01/2012
2	Single-Chain AntibodiesIBA 11/2008 - 07/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2007 - 05/2006
1	fludarabineIBA 02/2024
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 02/2024
1	treosulfanIBA 02/2024
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2024
1	Etoposide (VP 16)FDA LinkGeneric 11/2023

Therapy/Procedure

42	Therapeutics 05/2024 - 12/2003
40	Stem Cell Transplantation 02/2024 - 12/2003
31	Hematopoietic Stem Cell Transplantation 02/2024 - 02/2007
24	Transplantation 10/2023 - 02/2003
17	Immunotherapy 01/2024 - 05/2004
12	Drug Therapy (Chemotherapy) 11/2023 - 07/2009
4	Haploidentical Transplantation 10/2014 - 09/2004
2	Homologous Transplantation 11/2022 - 04/2015
2	Aftercare (After-Treatment) 01/2016 - 11/2014
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015 - 01/2004
2	Right Heart Bypass (Cavopulmonary Anastomosis) 11/2005 - 11/2005